SCHEDULES

SCHEDULE 2Amendment of the Human Medicines (Amendment etc.) (EU Exit) Regulations 2019

PART 10Amendment of Part 11 (amendment of Part 11 (Pharmacovigilance))

I1128

In regulation 160 (amendment of regulation 200 (amendment to study protocols for required studies))—

a

for paragraph (2) substitute—

2

In paragraph (2) for “to the body specified in paragraph (3)” to the end substitute—

to—

a

the body specified in paragraph (3) and the licensing authority (where not otherwise required by paragraph (3)), where the authorisation for the product is a UKMA(NI) or UKMA(UK);

b

the licensing authority, where the authorisation for the product is a UKMA(GB),

before their implementation.

b

for paragraph (3) substitute—

3

In paragraph (4)—

a

after “protocol is submitted” insert “ only ”;

b

after “paragraphs (2) and (3)(a)” insert “ (and is not submitted to the Pharmacovigilance Risk Assessment Committee) ”.

c

omit paragraphs (4) and (5).